NR 603 WEEK 3 QUIZ -ALL POSSIBLE QUESTION
Per 2013 ACC/AHA guidelines, which patient below would NOT benefit from statin therapy?
• - 42 yo male, LDL 162 mg/dL, 10 yr risk 4.9%
Which of the following patients should be on high-intensity statin therapy, if tolerated?
• 58 yo male w/ NSTEMI...
nr 603 week 3 quiz all possible question per 2013 accaha guidelines
which patient below would not benefit from statin therapy • 42 yo male
ldl 162 mgdl
10 yr risk 49 which of the followin
Written for
Chamberlain College Of Nursing
NR 603
All documents for this subject (245)
Seller
Follow
SmartMind
Reviews received
Content preview
1
NR 603 WEEK 3 QUIZ -ALL POSSIBLE
QUESTION
Per 2013 ACC/AHA guidelines, which patient below would NOT benefit from statin therapy?
- 42 yo male, LDL 162 mg/dL, 10 yr risk 4.9%
Which of the following patients should be on high-intensity statin therapy, if tolerated?
58 yo male w/ NSTEMI
- 71 yo female w/ DM, HTN, 10 yr risk 11.5%
- 41 yo male w/ baseline LDL 206 mg/dL
- 64 yo female w/ history of CVA
- All of the above
For someone who is intolerant to higher doses of statins, has tried 2-3 statins...what do we recommend?
There's no true guidelines on how many different statins to try before moving on to non-statin therapies, but
generally should try 3-4 different statins that differ in metabolism, hydro/lipophilic...and consider alternate day
dosing or twice a week dosing.
You have a patient with ASCVD but no comorbidities. Their LDL has gone down 30% from baseline and they are
on maximally tolerated statin therapy.
Is this patient appropriate for non-statin therapy and if so, what do you recommend?
It is appropriate to consider non-statin therapy for this pt. b/c they have ASCVD.
Since their LDL has gone down <50% (or if their LDL >70/non-HDL >100), they should be given ezetimibe 1st
line. PCSK9 would be second line.
IG is a 47 yo male with CAD s/p MI 2015. He is currently prescribed atorvastatin 20 mg/day. Pt states he is unable
to tolerate higher doses and refuses to try another statin. LDL 114 mg/dL. What is the next best step?
Alirocumab
YZ is a 67 yo female with DM and 10 year risk score 11.1%. She is currently prescribed atorvastatin 80 mg once
daily with reported adherence. Current LDL-C 141 mg/dL. What is the next best step for cardiovascular risk
reduction.
ezetimibe 10 mg once daily
TL is a 52 yo black male overbooked in your clinic today for evaluation of fasting labs per primary provider request.
He is without complaints.
Pertinent medications include amlodipine 10 mg/day and atorvastatin 20 mg/day
+ tobacco use, 3-4 beer/night Labs: TC 302, HDL 21, TG 1167, direct LDL 152, SCr 1.1
BP 145/78, height 74 inches, weight 113.4 kg
Increase atorvastatin to 40 mg/day
Start niacin ER 500 mg/day and titrate by 500 mg every month to target 2000 mg/day
Which of the following drugs inhibits factor IIa (thrombin) and factor Xa by activating antithrombin?
Heparin
Which of the following drugs have pharmacogenomic information in the FDA label? Select all correct answers
(there may be more than one).
A. Clopidogrel B. Atorvastatin C. Metoprolol D. Warfarin. (they all do)
Variants in which of the following genes have the most compelling evidence for association with clopidogrel
response?
CYP2C19
Brown a 45-year-old African American male has elevated lipids. What should the nurse practitioner do next?
*A thyroid stimulating hormone (TSH) level
Which of the following medications may have an unfavorable effect on a hypertensive patient's blood pressure?
Naproxen
Which group of medications would be detrimental if used to treat a patient who has heart failure
Verapamil
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller SmartMind. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $6.00. You're not tied to anything after your purchase.
